Clinical trial
Evaluation of [123I] MNI-187 and SPECT in Patients With Alzheimers Disease in…
NCT00456417 · Institute for Neurodegenerative Disorders, Other · Completed
Key facts
| NCT number | NCT00456417 |
|---|---|
| Title | Evaluation of [123I] MNI-187 and SPECT in Patients With Alzheimers Disease in Comparison to Healthy Subjects |
| Official title | Evaluation of [123I] MNI-187 and SPECT as a Marker of Beta-amyloid Protein Deposition in Subjects With Alzheimer Disease in Comparison to Healthy Subjects |
| Lead sponsor | Institute for Neurodegenerative Disorders, Other |
| Collaborators | Molecular NeuroImaging |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Alzheimers Disease |
| Intervention type | Drug |
| Interventions | 123-I MNI-187 Injection and Imaging Procedures |
| Enrollment | 30 |
| Start date | Apr 1, 2007 |
| Primary completion | Dec 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Apr 5, 2007 |
| Last update posted | Mar 14, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: